TLRY Weekly AnalysisTLRY formed a parabolic wedge bull flag which triggered last week. So far it is failing and testing the bull breakout gap around $40. The bulls will likely try to form a second entry for the wedge bull flag within the next few weeks. If instead the sell off continues, prices will likely test the tight trading range of the open around $20 and from there enter a trading range.
Marijuana
CGC Weekly AnalysisCGC has formed a failed bull breakout and small final flag reversal (failed breakout of tight trading range). It also tested the middle of the tight trading range from the previous all time high which was a target. However this is the first reversal attempt since the January rally and the selling pressure wasnt that strong. The bears need strong follow through in order to convince the market the reversal is in. If the market ignores the sell setup and instead prices continue to rally, the bulls will likely get a new all time high, or a test of the previous high.
GWPH Weekly AnalysisThe Bulls are getting trend resumption after testing the EMA and filling the buy climax gap at $150. Prices will likely reach a new all time high soon. There are signs of profit taking around the new all time high (sideways for past 8 weeks). A reversal down soon could become a second entry for the larger wedge reversal. If there is another buy climax prices would form a parabolic wedge reversal and likely correct for two legs sideways to down.
TLRY weekly analysisTLRY formed a parabolic wedge bull flag last week which triggered this week and will potentially lead to bull trend resumption. The bears appear to be exiting on a test of the previous weeks bear close but the bulls will need follow through over the next few weeks. If prices continue to sell off the bears will likely test the bull breakout gap around $32 and $27.
KSHB weekly analysisKSHB is in a bull flag trading range and larger trading range after making a measured move up based on the height of the opening range. Bears need a strong breakout below the $4 low, where the bulls will probably buy again. If the bears get a breakout below prices will likely test the $3 start of the bull spike or the tight trading range around $2.
EURUSD weekly analysisThe EURUSD (weekly) reversed down from a failed bull reversal this week. There are bull gaps below which are being tested. The bulls will try to form a nested wedge bull flag reversal for a large second leg up soon. If it fails, prices will likely test the low of the previous range around 1.044. The bulls need to keep atleast the breakout gap around 1.080 open. If it is filled, the bears will have an increased chance of a bear breakout below the range and larger second leg down from the May 2014 selloff. For now prices will likely remain range bound as both sides fight for follow through.
TSLA weekly analysis Bear breakout in TSLA from failed double bottom pullback. Bulls could not even trigger the setup (last week). Bull gaps below likely to be tested around $225 and $200. TSLA was in a trending trading range bull trend, which is now evoloving into a large trading range. Until one side gets a strong breakout, prices will likely remain range bound within a larger range made up of both trading ranges. If bears get strong follow through next week, prices will likely test the most recent higher low around $200, and possibly all the way down to the $125 start of the bull trend.
CGC weekly analysisCGC
Bull breakout from high 2 / nested wedge bull flag at EMA. Prob second bull leg up from Dec rally, but selling pressure above around $52. Mostly sidways in a large trading range since July 18. Probably some profit taking here or new all time high.
CRON weekly analysisCRON
CRON reversed down from a parabolic wedge and tested below the 1/28 bull gap and the previous all time high. Bulls still have gaps open below and are currently trying to close the bar on its high for a high 2 buy setup off the EMA. But decent selling pressure over past few weeks, possible second leg down before bulls return.
ACB weekly analysisACB 4/26
Failed L2/ nested H2 /Breakout pullback test of all time high in ACB. So far this week is a small doji bar, and small range of previous few weeks. Bull gaps still below, if prices test below last weeks bull bar prices will likely test the EMA and below the 8.00 big bull bar gap.
HEXO weekly analysisHEXO 4/26
Bull breakout of failed bear reversal, outside bull bar H2 variant, new all time high this week. Good buying pressure, still bull gaps open below, the most recent being just above the EMA at 7.75.
LEVB weekly analysisLEVB 4/26
Bull breakout from nested H2 at EMA, bull gaps open below. Possible second bull leg up from Jan rally. Selling pressure above around $6. Bulls need strong follow through above. Mostly sideways on higher time frame chart (monthly).
WEED weekly analysisWEED
WEED is in a broad bull channel with good buying pressure and no strong reversal yet. The bears recently attempted to form a lower high, but prices are stalled at the EMA and set up a nested high 2 /wedge bull flag. The bulls have a breakout gap below around $47.50. If it remains open, prices will likely test the all time high. A new all time high could form a wedge reversal down, at which point bulls will likely take profits and wait for two legs sideways to down before buying again, unless the reversal is strong.
Resistance & Support. Ascending Triangle Breakout?The news release from Tinley today was enough to test the resistance level at roughly 85c to 86c, which is the top of an Ascending Triangle!
It would be nice to see Tinley break through this resistance flush tmrw, Friday, or possibly next week & consolidate above the Ascending Triangle.
There's not much resistance until 1.13$ CAD if Tinley can breakout of this Ascending Triangle with volume.
We could be in for a Moon Shot everyone. Tinley appears ready to knock some public MJ Companies looking to enter the "infused beverage space" off of their High Horse!
SIML Simlatus up 924% in 15 days. CBD oil extractionNice uptrend since announcement of acquiring Proscere Bioscience Inc. manufacturer of Cold-Water Cannabis/Hemp Extraction Systems.
Please click like if you like.
This is educational only. Not stock advice or investment advice. Trade at your own risk, do your own due diligence. I own shares of this company.
443% up in 10 days!!! SIMLIt's taking off. Simlatus Corp makes industrial CBD extraction equipment. Just inked some distribution deals.
$PNTV is our 2-cent Cannabis play w/ 100 Percent Gain Potential!
=====================
Player's Network, Inc. (PNTV)
Float: 577.51M
Alert Price: $0.0226
Chart Analysis
Investor Presentation
Investor Portal
Message from CEO
eCommerce
Website | Recent News
========================
Members,
Are you ready for winner number 3?
We've just found what could be the biggest steal in the cannabis space at the moment.
Please turn your immediate attention to PNTV (Player's Network Inc.).
PNTV is one of the fasted growing companies in this sector.
Over the last 12 months, the Company has gone from a development stage company to a fully operational cannabis business. The business strategy is to grow by acquisitions, joint ventures, and new market opportunities in the US and Internationally.
The fact that PNTV is trading at just around two-cents has our heads spinning, especially when your consider the following.
They have recently uplisted to the OTCQB
Operate a fully functional eCommerce site which sells the highest quality CBD products made from the finest organic ingredients
$450 million in projected annual revenue via their cannabis production facilities in Argentina and Las Vegas
They are the Argentinian leader in legal sources of cannabis oil for epilepsy research, and is currently selling CBD products under its subsidiary Green Leaf PURE and will have access to low overhead, large-scale cannabis and Hemp-CBD cultivation and extraction capacity with global distribution channels anywhere cannabis and CBD products are able to be legally imported and sold.
Investor Portal to keep shareholders completely updated on all Company happenings
Trading on a nearly bottom'd out chart with what we believe to be little downside risk, and unlimited upside potential
Based on our research, we believe that PNTV is ridiculously undervalued, and could be trading at twice its current share price in the immediate future.
That being said, we are asking all of our members to start their research on PNTV immediately, and consider building a position tomorrow morning at 9:30AM EST
About Player’s Network, Inc. (OTCQB: PNTV)
Player’s Network (currently in the process of changing its name to Green Leaf Farms International, Inc. PNTV/GLFI) is a rapidly growing company in the marijuana industry with licensed grow operations in Las Vegas, Nevada and Jujuy, Argentina. Over the last 12 months, the Company has gone from a development stage company to a fully operational cannabis business. The business strategy is to grow by acquisitions, joint ventures, and new market opportunities in the US and Internationally.
Green Leaf Farms International is a rapidly growing company in the marijuana industry with licensed grow operations in Las Vegas, Nevada and Jujuy, Argentina. Over the last 12 months, the Company has gone from a development stage company to a fully operational cannabis business. The business strategy is to grow by acquisitions, joint ventures, and new market opportunities in the US and internationally.
Green Leaf Farms International has marijuana cultivation facilities in the United States and Argentina. Founded in 2014, Green Leaf Farms International currently operates a 27,000 sq ft facility in North Las Vegas, Nevada. Green Leaf Farms International and the Argentine Province of Jujuy have signed a deal to jointly develop 33,600 acres to cultivate a variety of CBD and THC rich cannabis genetics to serve both the domestic and the international markets. Canada legalized marijuana adult use in October 2018. As of February 2019, there are 30 states in the United States plus the District of Columbia that have legal medical marijuana use and 9 states that have adult recreational use. Green Leaf Farms International believes this trend of legalization of marijuana in the US and worldwide will continue and create tremendous growth opportunities for shareholders.
Establishing South American Market Leadership
On February 12th, 2019, Green Leaf Farms announced a Definitive Joint Venture Agreement with the Argentine government through its joint venture company Cannava (a Jujuy province state owned company) to develop fertile, organic farmland that occupies 33,600 acres (14,000 hectares), for growth, extraction, and exportation of essential cannabis oils and other hemp-based products to legal markets throughout the world. GLFI's Joint Venture with the Jujuy, Argentina government (through Cannava) will enable the company to supply, on a massive scale, the key ingredients used to produce an array of environmentally friendly hemp-based products, especially medical grade oils and isolates used for research and to treat an assortment of afictions
Green Leaf Farms International has partnered with the Argentine state-owned company Cannabis Avãtara to form the first governmental joint venture in the world specifically targeting cannabis and CBD. This joint venture is designed to create the largest producer of CBD products in the world with a grow operation that is 1,000 times greater in size than the largest cannabis farm in the United States. This massive undertaking will include the development of 33,600 acres of property to cultivate both CBD and cannabis products. To put this in perspective, Washington, D.C. is 43,700 acres, making Green Leaf Farms International’s newly developed cannabis farm 75% of the size of our nation's capital.
Project Overview:
14,000 hectares of licensed cultivation land on a 99 year lease.
Highly experienced and inexpensive agricultural labor force.
Perfect environmental conditions for cultivating high quality cannabis.
Can cultivate 11 months out of the year, 3 full crop cycles.
Operation and production is a “Tax Free” Zone.
All licenses provided by the government.
Green Leaf Farms Holdings
Green Leaf Farms Holdings holds all assets for seed-to-sale operations. Green Leaf Farms intends on using its brand when developing new ventures and/or through acquisitions. Due to different state laws, each state we move into into will likely have a new company incorporated to hold those assets.
Las Vegas Facility
Green Leaf Farms Las Vegas, is a 27,000 sq. ft. state-of-the-art facility that currently produces several product lines, is eagerly anticipating the first big harvest of 2019.
Green Leaf Pure eCommerce
PNTV provides consumers with the highest quality CBD products made from the finest organic ingredients via their eCommerce website.
Weed TV
weedtv.com is a niche social network and lifestyle channel destination for the marijuana industry. WeedTV.com is launching the “go-to” source for information, entertainment, products and services for people who relate to the marijuana lifestyle and an active social community.
WeedTV has its foundation in the creation, production, and wide-ranging monetization of high-quality television programming.
The network was created by successful, proven, highly-regarded Media and Entertainment Leaders who created brands like MTV. Baywatch, Nickelodeon, Players Network, A&E
WeedTV will be the media and entertainment center of the marijuana lifestyle – and the trusted, credible source of information, integrity, and medicinal resources.
Original Content
Besides user-generated content, WeedTV also features a large array of studio productions generating advertising revenue.
Recent Developments:
Players Network and Cannava Have Been Approved to Import Cannabis Seeds to Jujuy Province, Argentina to Propagate the World's Largest Cannabis Farm
Player’s Network, Inc. (OTCQB: PNTV) is in the process of changing its name to Green Leaf Farms International, Inc. PNTV/GLFI, a rapidly growing company in the worldwide cannabis market and CBD industries, with operations in Nevada and now Argentina, announced today that together with its Argentina joint venture partner, Cannava, it has received approval from the Argentine government to import cannabis seeds from the United States into Jujuy Province, Argentina.
This is the first time the Argentine government has approved such a venture. PNTV previously announced approval of seeds from a security standpoint, this approval, by the highest government agencies, was given exclusively to the joint venture with the goal of establishing Jujuy Province as the world’s leading supplier of cannabis oils, distillates, isolates, and biomass to a rapidly growing and underserved worldwide market.
As those knowledgeable of the industry know, there is an explosion of pharmaceutical, cosmetic, and health-related cannabis-infused products entering the global marketplace. At the present time most of these products are being introduced by small, start-up companies, although press reports indicate that the market demand is becoming so large and expanding so rapidly that a number of Fortune 500 companies in a wide range of industries including soft drink, adult beverage, cosmetic, pharmaceutical, and other health related industries are developing their own CBD-infused products.
This greatly increased demand for cannabis raw materials - CBD (and in some countries THC) Oils, Distillates and Isolates – will soon make these a commodity like other agricultural products. The company that dominates this market niche will be the one that establishes itself as the lowest cost, highest quality, reliable supplier. That supplier will be Green Leaf Farms International!
As previously announced, working in partnership with Jujuy Province, GLFI and its joint venture partner have negotiated a 99-year lease on 14,000 hectares or 34,600 acres (54 square miles) of prime agricultural land. The temperate climate near the equator allows virtually year-round growing conditions. In addition, working with the Argentine government, a tax-free trade zone has been established for the processing and worldwide distribution of the cannabis oils, distillates, isolates, and biomass grown on this land. Due to the quality of the land, ideal year-round growing conditions, low-cost agriculturally skilled labor force and, most importantly, absence of burdensome regulations and taxes, the company believes this joint venture with Argentina positions it to produce the highest quality, lowest cost raw materials that will enable GLFI to be the dominant player in this exploding worldwide market.
The initial genetics includes approximately 25,000 seeds of carefully selected strains to propagate in test plots. This first batch is scheduled to be delivered in Argentina this month. The Green Leaf Farms cultivation team on the ground there will immediately begin planting the initial plots.
These initial growths will allow our technical team to evaluate how the various strains react to the environment. Large scale cultivation of the chosen strains will begin in September. In addition to ideal growing conditions, the joint venture has ready access to hundreds of skilled agricultural workers in this area that will be required for this new industry being established to export large quantities of high quality medical and other full spectrum oils, distillates, and isolates to legal markets around the world.
Prior to the importation of the seeds Green Leaf Farms passed a rigorous security plan including all security equipment and protocols was developed, approved, and installed by the Argentina National Guard. The security protocol includes locking down the entire cultivation area with video surveillance, lighting, communication systems and armed guards which are all now in place.
Mark Bradley, CEO of Green Leaf Farms, states, “It has been a pleasure working with Gaston Morales, the CEO of Cannava. We share the same vision of how the cannabis industry in Jujuy can become a leading role model to the world as the cannabis industry evolves into a true commodity market.” Bradley adds, “Being among the first to view cannabis as a commodity, and meeting all the challenges we have now completed, has been rewarding in so many ways. Allowing our genetics to be imported to begin the cultivation process is a major milestone at a truly exciting time, not only for our company, but for the entire cannabis industry.”
Market Outlook:
Hemp CBD market predicted to grow nearly 40 times current size by 2022
Cannabis industry analysts at the Brightfield Group project the hemp-CBD market could hit $22 billion by 2022
Growing Demand for CBD Isolates and Distillates
CBD isolates and distillates is increasingly being used in a variety of products and industries to include pharmaceutical research, health & wellness, beauty, pet care, beverages, mental health and wellness, textiles, and more.
With revenue of $5.8 billion-$6.6 billion, sales of legal recreational and medical cannabis in the United States in 2017 topped those of Oreos and organic produce combined.
The data – published in the newly released Marijuana Business Factbook – illustrates how quickly the legal U.S. marijuana industry has grown.
It now rivals Americans’ collective spending on Netflix subscriptions – and will likely surpass McDonald’s annual U.S. revenue now that California’s massive new legal industry is getting off the ground.
By the end of 2019, sales of legal cannabis in the United States could overtake those of firearms and ammunition, an industry with a huge amount of influence on Capitol Hill.
Continued growth in mature medical and recreational markets, legalization in new states and further development of recently launched MMJ and rec industries will be the primary drivers of growth for the U.S. marijuana industry over the coming years.
But legal sales represent just a fraction of the estimated total potential demand for cannabis in the United States, which is around $50 billion-$55 billion, including black-market demand. This is how much revenue the industry could generate if the federal government legalized marijuana nationwide.
Technical Analysis:
You really can't ask for a better entry point than what we have right now.
PNTV is trading on a nearly bottom'd out chart with what we believe to be little downside risk, and unlimited upside potential.
A run back up to its 52-week high of $0.083, would show traders gains of over +267%!
We've done our very own chart analysis, and see the potential for a move of over +165%!
This could be the biggest steal in the cannabis space...
Start your research on PNTV immediately, and consider building a position tomorrow morning at 9:30AM EST
(*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.)
Best Regards,
The PennyStock101 Team
Don't Miss Our Next Huge Winner...
Text 'GAINS' to '67076'
to have our Trade Alerts
Delivered Direct
to your Cell Phone.
(There is no charge.
Msg&data rates may apply.)
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated ten thousand dollars by Awareness Shore Thing LLC to conduct investor relations advertising and marketing for PNTV. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
$MLNT Breaks Out Ahead of Upcoming 9 Presentations at ECCMIDVery undervalued stock. 52 Week High was $46.00 52 Week Low was $3.22 Revenue for the 4th quarter of 2018 was $35.5 million, an 739% increase year over year. Total revenue for the year is $96.4 million. Could do 2x-3x from this level.
Key data presentations at ECCMID 2019 include:
Integrated Symposium Presentations
•“Update on acute bacterial skin and skin structure infection: current challenges and new therapeutic agents,” chaired by Javier Garau, M.D., Ph.D. (Saturday, April 13, 1:30 - 3:30 p.m., Hall D)
•“Light and shadows in the management of serious MDR G-negative infections,” chaired by Matteo Bassetti, M.D. (Monday, April 15, 4:00 p.m. – 6:00 p.m., Hall F)
Oral Presentation
•Abstract No. 3623 (Sunday, April 14, 11:00 a.m. - 12:00 p.m. CET, Exhibit Hall L): Development and Validation of a Risk Stratification Score for a Mixed Gram-Negative and Gram-Positive Infections among Patients Hospitalized with Skin and Skin Structure Infections in the U.S., Y. Tabek, BD.
Poster Presentations
Meropenem/vaborbactam (VABOMERE®)
•Abstract No. 8308 (Saturday, April 13, 3:30 - 4:30 p.m. CET, Paper Poster Area): Activity of meropenem-vaborbactam and single-agent comparators against KPC-producing Enterobacterales isolates from European countries (2016-2018) stratified by infection type, M. Castanheira, JMI Laboratories
•Abstract No. 2825 (Monday, April 15, 12:30 - 1:30 p.m. CET, Paper Poster Area): Multicenter Evaluation of Meropenem/Vaborbactam MIC Results for Enterobacteriaceae and Pseudomonas aeruginosa Using MicroScan Dried Gram-Negative MIC Panels, A. Harrington, Loyola University
•Abstract No. 4780 (Monday, April 15, 12:30 - 1:30 p.m. CET, Paper Poster Area): ETEST meropenem/vaborbactam for antimicrobial susceptibility testing of Enterobacterales and Pseudomonas aeruginosa: performance results from a multi-centre study, C. Anglade, bioMérieux, Inc.
•Abstract No. 7426 (Tuesday, April 16, 12:30 - 1:30 p.m. CET, Paper Poster Area): An FDA-approved study for an AST disc 510(k) submission: comparison of an oxoid AST disc to a predicate AST disc for meropenem-vaborbactam, N. Hunter, Thermo Fisher Scientific
Delafloxacin (BAXDELA®)
•Abstract No. 6363 (Monday, April 15, 1:30 - 2:30 p.m. CET, Paper Poster Area): Delafloxacin tentative ECOFF values for common Gram-positive and Gram-negative bacteria, G. Menchinelli, Università Cattolica del Sacro Cuore
Oritavancin (ORBACTIV®)
•Abstract No. 4151 (Monday, April 15, 1:30 - 2:30 p.m. CET, Paper Poster Area): Oritavancin Activity against Staphylococcus aureus Clinical Isolates Causing Serious Infections in Hospitalized Patients in Europe (2017-2018), C. Carvalhaes, JMI Laboratories
marketwirenews.com
NBEV: Classic Abcd Bull pattern Weekly ABCD bull pattern
NBEV deal with Walmart news could help drive this bull pattern